It should be clarified that certain changes which have the highest potential impact on the quality, safety or efficacy of medicinal products require a complete scientific assessment, in the same way as for the evaluation of new marketing authorisation applications.
Recital 4, Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination o…
In forcesince 24 Nov 2008